glp-1 receptor agonists should be avoided in patients with and next-generation metabolic hormone therapies chronic kidney disease “Weighing In” on GLP-1 Receptor

The advent of monoclonal antibodies targeted towards receptors on the surface of B cells allows physicians to turn the immune system against itself, in a sense, and eradicate self-reactive B cells that underlie lupus pathology

Autoimmune digestive diseases Crohns disease can affect the absorption of B12, since the ileum is often affected, according to British researchers (10)

How much do GLP-1 weight-loss drugs cost under Medicare's Bridge program

Mycorrhizal frequency, physiological parameters, and yield of strawberry plants inoculated with endomycorrhizal fungi and rhizosphere bacteria

Together, LIVVs TES/CJC/IPA is a comprehensive peptide therapy blend for health optimization and rejuvenation

A group of Croatian patients with dwarfism and multiple hormone deficiencies (GH, TSH, PRL, FSH/LH) related to homozygous PROP1 mutations do not experience diabetes mellitus, early grey hair, or death (40)